Important announcement concerning Temple Health and Keystone First. Our provider agreement with Keystone First is scheduled to end on July 31st. Click the link below to learn about your options for continuing care at Temple Health.

Learn More
800-TEMPLE-MED Schedule Appointment
SEARCH TEMPLE HEALTH

Dr. Ellen Unterwald Offers Insight for Philadelphia Inquirer Article about Proposed Pennsylvania Psilocybin Legislation

View All News

Ellen Unterwald, PhD, Chair and Professor in the Department of Neural Sciences and Director and Professor in the Center for Substance Abuse Research at the Lewis Katz School of Medicine at Temple University, offered insight to the Philadelphia Inquirer for an article about the Public Health Benefits of Psilocybin Act, a bill introduced in Pennsylvania’s House of Representatives that would establish a framework for clinical studies of psilocybin, the active ingredient in magic mushrooms.